Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (0LIF)

Market Closed
20 Jul, 15:30
LSE LSE
$
29. 22
-0.37
-1.2504%
$
- Market Cap
- P/E Ratio
- Div Yield
563 Volume
-8.23 Eps
$ 29.59
Previous Close
Add Transaction
Day Range
29.09 30.08
Year Range
18 41.5
Want to track 0LIF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Ultragenyx Pharmaceutical Inc. logo
0LIF Ultragenyx Pharmaceutical Inc.
5 May 2026
-
-
Ultragenyx Pharmaceutical Inc. logo
0LIF Ultragenyx Pharmaceutical Inc.
12 Feb 2026
-
-

0LIF Earnings Reports FAQ

What is the earnings per share (EPS) for 0LIF?

The current EPS is -8.23.

What is the company's earnings growth rate?

Ultragenyx Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Ultragenyx Pharmaceutical Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Ultragenyx Pharmaceutical Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0LIF at this time, as Ultragenyx Pharmaceutical Inc has no recent EPS data to calculate it.